More than 100,000 people in the United States annually consume the edible false morel mushroom, Gyromitra esculenta (GE). This fungus contains 11 hydrazine analogues, of which acetaldehyde methylformylhydrazone (AMFH), pentanal methylformylhydrazone (PMFH), N-methyl-N-formylhydrazine (MFH), and N-methylhydrazine (MH) were shown to be carcinogenic in mice in this laboratory. In the present grant, we have set up the carcinogenesis experiments and all have progressed well. The GE feeding induced tumors in the lungs, blood vessels, forestomachs, and cecums of mice. 3Methylbutanal N-methyl-N-formylhydrazone (3-MBMFH) and hexanal N-methyl-N-formylhydrazone (HMFH) have already induced statistically significant incidences of tumors in the lungs, preputial glands, and liver. Also, possible metabolic intermediates derived from MFH that could act as the ultimate carcinogenic species have been identified by studying the oxidative degradation of this hydrazine. Products that form under chemically oxidizing conditions have been identified, too. In this proposal, we intend to continue (1) to determine the tumor-inducing ability of the fresh GE by a lifelong feeding study in mice, (2) to study the tumorigenicity of 3-MBMFH and HMFH ingredients of the mushroom by lifelong oral administration to mice, (3) to measure chemically the amounts of AMFH, MFH, and MH in the mushroom used for the feeding experiment, and (4) to investigate the electrochemical oxidation of WH, MH, and formylhydrazine (FH) through the use of radical trapping agents. The results of the proposed study will allow us to determine the environmental significance of mushroom consumption and their toxins and reveal the mechanism of action of the three main carcinogenic hydrazines, particularly MFH (the most potent carcinogen of this series). In a recent study, a variety of tumors were induced in animals fed another fresh mushroom, the cultivated Agaricus bisporus. The proposed experiments likely will provide positive findings in a field of current interest. Virtually nothing is known about the mechanism of action of these highly carcinogenic hydrazines. Our proposed studies should identify the oxidative processes involves. No new studies are proposed. Only the completion of previously approved investigations are requested.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA044075-04A1
Application #
3186622
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1987-01-01
Project End
1991-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Toth, B; Patil, K; Pyysalo, H et al. (1992) Cancer induction in mice by feeding the raw false morel mushroom Gyromitra esculenta. Cancer Res 52:2279-84
Gannett, P M; Dalal, N S; Shi, X L et al. (1991) 8-Hydroxy-2'-deoxyguanosine formation during the catalytic oxidation of hydrazines in the presence of 2'-deoxyguanosine. Chem Biol Interact 80:57-72
Toth, B; Taylor, J; Gannett, P (1991) Tumor induction with hexanal methylformylhydrazone of Gyromitra esculenta. Mycopathologia 115:65-71
Gannett, P M; Garrett, C; Lawson, T et al. (1991) Chemical oxidation and metabolism of N-methyl-N-formylhydrazine. Evidence for diazenium and radical intermediates. Food Chem Toxicol 29:49-56
Toth, B (1988) Toxicities of hydrazines: a review. In Vivo 2:209-42
Toth, B; Raha, C R (1987) Carcinogenesis by pentanal methylformylhydrazone of Gyromitra esculenta in mice. Mycopathologia 98:83-9